How many people stop Wegovy and Mounjaro?
Between 36% and 65% stop early or take a break, and the share is highest among those who take the medicine for obesity without having diabetes.
In an analysis of about 195,000 new users, 36.5% stopped within 12 months. In a register of over 125,000 people with obesity, it was 46.5% of those with type 2 diabetes and 64.8% of those without.[1]
Figures from three large analyses, as reported in the review article. They usually do not show why each person stopped.[1]
Stopping is often a break and not the same as giving up. Among those who stopped, 36.3 to 47.3% started again within a year.[1]
What are the most common reasons for stopping?
The most common reasons are stomach and bowel side effects and the price, and some stop because the weight loss is smaller than expected.
Nausea, vomiting and diarrhoea play the biggest part. In 64 randomised trials with 16,783 participants, they led to treatment being stopped in up to about 12% of people, compared with about 2% on placebo (an inactive dummy treatment). So the vast majority in the studies did not stop for that reason.[1]
In an interview study, 50% of those who had stopped named the price as a main reason. In a survey, 25% answered that they did not lose weight as expected. It helps to know the realistic expectations from the start.[1]
What characterises those who stay on treatment?
Those who stay on treatment have more often been given thorough guidance and lose more weight along the way.
When the treatment works, the effect is clear: average weight losses reach 15 to 20% or more compared with placebo, and those who lose the most weight more often stay on treatment.[1]
Those who continue have also more often been given thorough guidance on effects, side effects, dose escalation and diet. It is therefore worth using the doctor actively, especially in the first months.[1]
Read also: What happens when you stop Wegovy or Mounjaro? · Thinking of stopping Wegovy or Mounjaro? Here is what you can do
Questions and answers about stopping GLP-1 medication
Is stopping Wegovy or Mounjaro always permanent?
How many people stop because of side effects?
How much weight do people lose on average on Wegovy or Mounjaro?
Sources
- Ceriello A, Prattichizzo F, Mastan Sheik Abdullah AR, et al. Causes and consequences of discontinuation of GLP1RAs or tirzepatide. Nature Reviews Endocrinology 2026;22(9):530-542. doi.org